Primary Systemic Anaplastic Large Cell Lymphoma
Differential Diagnosis
ALCL may be EMA and infrequently keratin positive (mostly older reports)
Primary Systemic Anaplastic Large Cell Lymphoma |
Anaplastic Variant Large B Cell Lymphoma |
ALK Positive Large B Cell Lymphoma |
Marked anaplasia |
Marked anaplasia |
Monomorphic with round nuclei |
Frequently sinusoidal |
Frequently sinusoidal |
Frequently sinusoidal |
CD30 >90% |
CD30 variable |
CD30 negative |
EMA 60% |
EMA 33% |
EMA positive |
T lineage |
B lineage |
B lineage |
ALK immunohistology 60-85% positive |
ALK immunohistology negative |
ALK immunohistology 100% positive |
Majority of ALK positive cases show ALK translocation such as t(2;5) or t(1:2) |
Lack ALK translocation |
Rare cases reported with clathrin-ALK t(2:17) gene rearrangement |
ALCL may lack T markers and require genetic analysis to determine lineage
Primary Systemic ALCL |
Classical Hodgkin Lymphoma |
PAX5 negative |
Usually PAX5 positive |
Rarely CD15 positive |
Usually CD15 positive |
Usually clusterin positive |
Rarely clusterin positive |
Usually positive for T cell antigens |
Rarely positive for T cell antigens |
Usually T cell receptor gene rearrangement positive |
Usually T cell receptor gene rearrangement negative |
Hallmark cells usually present |
Reed Sternberg cells usually present |
Lacks conspicuously large nucleoli |
Very large nucleoli |
Both share anaplastic cytology, T lineage and CD30 reactivity
Primary Systemic ALCL |
Primary Cutaneous ALCL |
Most under age 30 |
Adult, rare in children |
Primary nodal involvement |
Primary cutaneous involvement |
ALK+ 60-85% of cases |
ALK negative to rare |
EMA+ 60% of cases |
EMA negative to rare |
Majority of ALK positive cases show ALK translocation such as t(2;5) or t(1;2) |
Usually negative for t(2;5) and t(1;2) |
Secondary nodal involvement may be seen in primary cutaneous cases in the presence of widespread cutaneous disease
Secondary cutaneous involvement may be seen in primary systemic cases